Topics: rTMS | Transcranial Magnetic Stimulation

Transcranial magnetic stimulation (TMS) is no longer just for depression, with 6 FDA approvals and 7 different devices to choose from. Adam Strassberg looks at how well this intervention stacks up against ECT and medications. Includes a buyer’s guide to the latest machines.

Topics: Antidepressants | Benzodiazepines | Deprescribing | Withdrawal

What do you do when a patient comes to you on a high dose of Adderall and Klonopin without any clear reason to be on them? Swapnil Gupta tackles this in part II of our interview on deprescribing, and describes how to fine-tune and microdose antidepressants and benzodiazepines to manage withdrawal symptoms.

Topics: ADHD | Alpha Agonists

Now that guanfacine ER (Intuniv) and clonidine ER (Kapvay) have gone generic, we review the 40-years of research that earned them FDA approval in ADHD. Along the way we’ll consider their off-label use in anxiety, addiction, insomnia, and self-harm. Plus: When to use the ER, the instant release, or the oft-forgotten transdermal patch.

Topics: Antidepressant Augmentation | Antipsychotics | Aripiprazole | Mortality

The study is not without flaws, but it raises some concerns about the long term health-effects of antipsychotic augmentation.

Oxytocin levels tend to fluctuate in synchrony when people are in strong, connected relationships, from the mother-child bond to romantic partnerships. A new study extended that to the therapist-patient dyad by comparing the change in oxytocin levels for patient and therapist during each session of psychotherapy for depression. The greater the synchrony in the oxytocin flux, the better the therapy outcomes.

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit.